High content screening of patient-derived cell lines highlights the potential of non-standard chemotherapeutic agents for the treatment of glioblastoma-Reference-Cited by-同舟云学术

High content screening of patient-derived cell lines highlights the potential of non-standard chemotherapeutic agents for the treatment of glioblastoma

Published:2018-03-02 Issue:3 Volume:13 Page:e0193694
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Yu Kenny Kwok-Hei,Taylor Jessica T.,Pathmanaban Omar N.,Youshani Amir Saam,Beyit Deniz,Dutko-Gwozdz Joanna,Benson Roderick,Griffiths Gareth,Peers Ian,Cueppens Peter,Telfer Brian A.,Williams Kaye J.,McBain Catherine,Kamaly-Asl Ian D.,Bigger Brian W.^ORCID

Funder

The Christie Charitable Fund

The Brain Tumour Charity

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference46 articles.

1. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial;R Stupp;Lancet Oncol,2009

2. Scale to predict survival after surgery for recurrent glioblastoma multiforme;JK Park;J Clin Oncol,2010

3. PCV chemotherapy for recurrent glioblastoma;F Schmidt;Neurology,2006

4. Cetuximab, bevacizumab, and irinotecan for patients with primary glioblastoma and progression after radiation therapy and temozolomide: a phase II trial;B Hasselbalch;Neuro Oncol,2010

5. Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis;SA Chowdhary;J Neurooncol,2015

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of local immunogenic cell death-inducing chemotherapy and DNA vaccine increases the survival of glioblastoma-bearing mice;Nanomedicine: Nanotechnology, Biology and Medicine;2023-06

2. Glioblastoma and the search for non-hypothesis driven combination therapeutics in academia;Frontiers in Oncology;2023-01-17

3. Inhibition of Protein Disulfide Isomerase (PDIA1) Leads to Proteasome-Mediated Degradation of Ubiquitin-like PHD and RING Finger Domain-Containing Protein 1 (UHRF1) and Increased Sensitivity of Glioblastoma Cells to Topoisomerase II Inhibitors;ACS Pharmacology & Translational Science;2022-12-07

4. Graphene Oxide Nanoscale Platform Enhances the Anti‐Cancer Properties of Bortezomib in Glioblastoma Models;Advanced Healthcare Materials;2022-11-11

5. CDC20 regulates sensitivity to chemotherapy and radiation in glioblastoma stem cells;PLOS ONE;2022-06-23